Get started
Author

Maorong Fu

ORCID: 0009-0007-9657-2482
Observed ORCID: 0009-0007-9657-2482
OpenAlex ID: A5045361663
The JAK/STAT signaling pathway: from bench to clinic
2021 · Xiaoyi Hu, Jing li, et al. · Signal Transduction and Targeted Therapy · 2,577
PDF
EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors
2023 · Dan Li, Xianling Guo, et al. · Science Advances · 94
Injectable and photocurable CAR-T cell formulation enhances the anti-tumor activity to melanoma in mice
2022 · Weilin Zhou, Sibei Lei, et al. · Biomaterials · 62
Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice
2023 · Jing Li, Weilin Zhou, et al. · Cancer Letters · 13
CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al. · Molecular Cancer Therapeutics · 4
Abstract 260: EpCAM-CD3 bispecific antibody-encoding mRNA delivered by lung targeted lipid nanoparticles suppresses orthotopic lung tumor growth.
2026 · Dong Wang, Gang Liu, et al. · Cancer Research
Figure S2 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Data from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S5 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S3 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S9 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S7 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S1 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Supplementary Table S1 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S4 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S6 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Figure S8 from CD24-Targeted CAR-T Cells Mediated Long-term Antitumor Efficacy through Activation of Endogenous Tumor Immune Responses
2025 · Yong Huang, Xiao Yang, et al.
Works count: 17
Citation count: 2,740
H-index: 4
I10-index: 4
Year
Topic
Type